Index RUT P/E - EPS (ttm) -3.65 Insider Own 16.66% Shs Outstand 164.67M Perf Week -3.80%
Market Cap 7.87B Forward P/E - EPS next Y -3.84 Insider Trans -1.13% Shs Float 139.21M Perf Month 10.56%
Income -519.21M PEG - EPS next Q -0.89 Inst Own 87.24% Short Float 11.74% Perf Quarter 1.35%
Sales 0.74M P/S 10638.64 EPS this Y 12.47% Inst Trans 6.36% Short Ratio 16.30 Perf Half Y 29.98%
Book/sh 9.77 P/B 4.82 EPS next Y -13.79% ROA -36.03% Short Interest 16.34M Perf Year 68.50%
Cash/sh 9.52 P/C 4.95 EPS next 5Y - ROE -40.73% 52W Range 15.44 - 51.00 Perf YTD 64.33%
Dividend Est. - P/FCF - EPS past 5Y -36.05% ROI -30.58% 52W High -7.59% Beta 1.43
Dividend TTM - Quick Ratio 15.42 Sales past 5Y 11.11% Gross Margin -1323.58% 52W Low 205.24% ATR (14) 1.70
Dividend Ex-Date - Current Ratio 15.42 EPS Y/Y TTM -16.27% Oper. Margin -80961.32% RSI (14) 49.76 Volatility 3.73% 3.51%
Employees 378 Debt/Eq 0.05 Sales Y/Y TTM -97.49% Profit Margin -69973.99% Recom 1.07 Target Price 59.92
Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q 12.28% Payout - Rel Volume 0.76 Prev Close 47.75
Sales Surprise -100.00% EPS Surprise -4.56% Sales Q/Q -100.00% Earnings Aug 07 AMC Avg Volume 1.00M Price 47.13
SMA20 -1.13% SMA50 4.72% SMA200 23.83% Trades
Volume 769,749 Change -1.30%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-16-24 Reiterated Needham
Buy
$46 → $62
Jul-12-24 Initiated Barclays
Overweight
$52
Jul-08-24 Initiated Jefferies
Buy
$63
Apr-12-24 Reiterated Needham
Buy
$36 → $46
Apr-10-24 Upgrade Raymond James
Outperform → Strong Buy
$36 → $48
Mar-11-24 Initiated Piper Sandler
Overweight
$43
Jan-05-24 Upgrade BofA Securities
Neutral → Buy
$31 → $34
Jan-04-24 Initiated Wedbush
Outperform
$41
Nov-16-23 Initiated Raymond James
Outperform
$30
Feb-28-23 Upgrade JP Morgan
Neutral → Overweight
$32 → $38
Dec-14-22 Initiated Needham
Buy
$31
Oct-21-22 Initiated Oppenheimer
Outperform
$30
May-20-22 Initiated BofA Securities
Neutral
$24
Mar-01-22 Upgrade Stifel
Hold → Buy
$36 → $26
Sep-23-21 Initiated Stifel
Hold
$34
Aug-12-21 Downgrade Goldman
Buy → Neutral
$49 → $27
May-18-21 Initiated Goldman
Buy
$49
May-21-20 Initiated H.C. Wainwright
Buy
$55
Mar-09-20 Initiated JP Morgan
Neutral
$32
Mar-09-20 Initiated Guggenheim
Buy
$50
Show Previous Ratings
Today 06:00AM
Oct-21-24 04:05PM
Oct-07-24 09:00AM
Aug-07-24 04:05PM
Jul-31-24 04:05PM
12:00PM
Loading…
Jul-11-24 12:00PM
Jul-10-24 05:58AM
Jul-08-24 04:05PM
(GlobeNewswire) +5.46%
+10.97%
Jun-08-24 09:00AM
Jun-05-24 04:05PM
Jun-04-24 06:00AM
May-09-24 03:41PM
May-08-24 09:58PM
04:02PM
May-01-24 04:05PM
03:34PM
Loading…
Apr-09-24 03:34PM
Apr-08-24 11:36AM
Apr-04-24 04:05PM
Mar-28-24 04:05PM
Feb-26-24 05:20PM
04:05PM
Feb-20-24 04:05PM
Feb-01-24 04:05PM
Jan-17-24 09:55AM
Jan-04-24 07:00AM
Nov-09-23 09:10AM
Nov-08-23 11:30AM
Nov-07-23 10:14AM
Nov-06-23 05:50PM
04:55PM
04:05PM
Loading…
04:05PM
Nov-01-23 07:00AM
Oct-31-23 04:15PM
Oct-23-23 04:06PM
(Investor's Business Daily) -34.38%
+14.52%
01:48PM
12:04PM
10:07AM
(Investor's Business Daily)
Oct-22-23 02:30AM
Oct-19-23 07:02AM
Oct-16-23 03:19PM
(Investor's Business Daily) +14.08%
09:45AM
Oct-13-23 02:54PM
11:50AM
Oct-04-23 04:05PM
Sep-20-23 07:01AM
Sep-19-23 07:00AM
Aug-17-23 04:05PM
Aug-09-23 02:13PM
Aug-08-23 05:50PM
04:05PM
Aug-03-23 04:05PM
Aug-01-23 02:34PM
(American City Business Journals) +20.00%
07:00AM
Jul-06-23 09:59AM
Jun-09-23 08:29AM
Jun-08-23 04:05PM
May-24-23 04:05PM
May-13-23 08:19AM
May-10-23 06:10AM
May-09-23 09:40AM
(Thomson Reuters StreetEvents)
May-08-23 05:25PM
04:02PM
May-03-23 10:00AM
09:55AM
May-01-23 04:05PM
10:01AM
Apr-19-23 07:15AM
Apr-13-23 04:05PM
Apr-06-23 07:00AM
Mar-22-23 11:29AM
Mar-11-23 03:27AM
Mar-07-23 04:02PM
Mar-02-23 09:15PM
(GlobeNewswire) -11.72%
+8.78%
Mar-01-23 04:17PM
Feb-27-23 06:25PM
04:05PM
Feb-21-23 04:05PM
Feb-02-23 12:00PM
07:00AM
Jan-23-23 05:31AM
Jan-12-23 03:25AM
Jan-03-23 07:00AM
Dec-31-22 06:15AM
Dec-26-22 08:14AM
Dec-19-22 07:00AM
Dec-08-22 06:19AM
Dec-07-22 04:05PM
Nov-10-22 05:48AM
(Simply Wall St.) +13.34%
Nov-09-22 04:05PM
Nov-07-22 05:55PM
04:05PM
Nov-02-22 10:01AM
09:54AM
Nov-01-22 04:05PM
Oct-24-22 11:07AM
Oct-13-22 11:05AM
Sep-22-22 07:00AM
Sep-01-22 04:05PM
Aug-31-22 04:05PM
Aug-30-22 09:55AM
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kelsey Stephen Michael See Remarks Oct 14 '24 Option Exercise 4.09 16,666 68,164 281,074 Oct 16 04:07 PM Kelsey Stephen Michael See Remarks Oct 14 '24 Sale 49.49 16,666 824,804 264,408 Oct 16 04:07 PM Horn Margaret A Chief Operating Officer Oct 11 '24 Option Exercise 4.09 50,000 204,500 182,320 Oct 15 05:31 PM Horn Margaret A Chief Operating Officer Oct 11 '24 Sale 50.34 50,000 2,517,055 132,320 Oct 15 05:31 PM GOLDSMITH MARK A See Remarks Oct 11 '24 Option Exercise 4.09 30,000 122,700 330,170 Oct 15 05:30 PM GOLDSMITH MARK A See Remarks Oct 11 '24 Sale 50.36 30,000 1,510,773 300,170 Oct 15 05:30 PM Anders Jack Chief Financial Officer Oct 11 '24 Option Exercise 2.68 10,000 26,800 108,932 Oct 15 05:30 PM Anders Jack Chief Financial Officer Oct 11 '24 Sale 50.30 10,000 502,979 98,932 Oct 15 05:30 PM Cislini Jeff General Counsel Oct 11 '24 Option Exercise 36.57 6,000 219,420 51,634 Oct 15 05:29 PM Cislini Jeff General Counsel Oct 11 '24 Sale 50.17 6,000 301,027 45,634 Oct 15 05:29 PM STEPHEN M. KELSEY Officer Oct 14 '24 Proposed Sale 50.48 16,666 841,300 Oct 15 08:03 AM MARK A GOLDSMITH Director Oct 11 '24 Proposed Sale 49.50 30,000 1,485,000 Oct 11 04:22 PM JEFFREY TODD CISLINI Officer Oct 11 '24 Proposed Sale 49.50 6,000 297,000 Oct 11 04:21 PM JACK LEE ANDERS Officer Oct 11 '24 Proposed Sale 49.50 10,000 495,000 Oct 11 04:21 PM MARGARET A HORN Officer Oct 11 '24 Proposed Sale 49.50 50,000 2,475,000 Oct 11 04:21 PM Weber Barbara Director Oct 08 '24 Sale 48.02 5,200 249,716 13,065 Oct 10 04:16 PM BARBARA L WEBER Director Oct 08 '24 Proposed Sale 47.34 5,200 246,168 Oct 08 04:23 PM GOLDSMITH MARK A See Remarks Oct 01 '24 Option Exercise 4.09 10,000 40,900 310,170 Oct 03 04:33 PM GOLDSMITH MARK A See Remarks Oct 01 '24 Sale 44.93 10,000 449,322 300,170 Oct 03 04:33 PM MARK A GOLDSMITH Director Oct 01 '24 Proposed Sale 45.35 10,000 453,500 Oct 01 04:33 PM Anders Jack Chief Financial Officer Sep 16 '24 Sale 44.19 2,244 99,152 98,932 Sep 18 04:18 PM GOLDSMITH MARK A See Remarks Sep 16 '24 Sale 44.19 11,715 517,631 300,170 Sep 18 04:18 PM Horn Margaret A Chief Operating Officer Sep 16 '24 Sale 44.19 4,331 191,367 132,320 Sep 18 04:17 PM Kelsey Stephen Michael See Remarks Sep 16 '24 Sale 44.19 4,665 206,124 264,408 Sep 18 04:17 PM Cislini Jeff General Counsel Sep 16 '24 Sale 44.19 1,454 64,245 45,634 Sep 18 04:16 PM Anders Jack Officer Sep 16 '24 Proposed Sale 42.12 1,832 77,164 Sep 16 07:06 PM Kelsey Stephen Michael Officer Sep 16 '24 Proposed Sale 42.12 4,601 193,794 Sep 16 06:41 PM Horn Margaret A Officer Sep 16 '24 Proposed Sale 42.12 4,271 179,895 Sep 16 06:22 PM Cislini Jeff Officer Sep 16 '24 Proposed Sale 42.12 1,433 60,358 Sep 16 05:37 PM Anders Jack Officer Sep 16 '24 Proposed Sale 42.12 1,832 77,164 Sep 16 05:24 PM GOLDSMITH MARK A Officer Sep 16 '24 Proposed Sale 42.12 11,561 486,949 Sep 16 05:15 PM Kelsey Stephen Michael See Remarks Sep 13 '24 Option Exercise 4.09 16,667 68,168 285,740 Sep 16 04:05 PM Kelsey Stephen Michael See Remarks Sep 13 '24 Sale 43.32 16,667 722,087 269,073 Sep 16 04:05 PM STEPHEN M. KELSEY Officer Sep 13 '24 Proposed Sale 41.97 16,667 699,514 Sep 13 04:23 PM BARBARA L WEBER Officer Aug 21 '24 Proposed Sale 44.83 1,808 81,053 Aug 21 04:14 PM Kelsey Stephen Michael See Remarks Aug 13 '24 Option Exercise 4.09 16,667 68,168 285,740 Aug 15 04:48 PM Kelsey Stephen Michael See Remarks Aug 13 '24 Sale 42.98 16,667 716,389 269,073 Aug 15 04:48 PM STEPHEN M. KELSEY Officer Aug 13 '24 Proposed Sale 42.98 16,667 716,348 Aug 13 04:25 PM GOLDSMITH MARK A See Remarks Aug 01 '24 Option Exercise 4.09 10,000 40,900 321,885 Aug 02 05:35 PM GOLDSMITH MARK A See Remarks Aug 01 '24 Sale 45.88 10,000 458,827 311,885 Aug 02 05:35 PM MARK A GOLDSMITH Director Aug 01 '24 Proposed Sale 45.64 10,000 456,400 Aug 01 04:29 PM Kelsey Stephen Michael See Remarks Jul 15 '24 Option Exercise 4.09 16,667 68,168 285,740 Jul 17 04:07 PM Kelsey Stephen Michael See Remarks Jul 15 '24 Sale 46.47 16,667 774,516 269,073 Jul 17 04:07 PM GOLDSMITH MARK A See Remarks Jul 12 '24 Option Exercise 4.09 25,000 102,250 336,885 Jul 16 05:05 PM GOLDSMITH MARK A See Remarks Jul 12 '24 Sale 45.05 25,000 1,126,205 311,885 Jul 16 05:05 PM GOLDSMITH MARK A See Remarks Jul 12 '24 Sale 45.01 10,000 450,117 25,424 Jul 16 05:05 PM Cislini Jeff General Counsel Jul 09 '24 Sale 40.83 2,399 97,951 47,088 Jul 10 04:36 PM Patel Sushil Director Jul 09 '24 Option Exercise 16.80 2,155 36,204 22,103 Jul 10 04:36 PM Patel Sushil Director Jul 09 '24 Sale 44.00 2,155 94,820 19,948 Jul 10 04:36 PM Cislini Jeff General Counsel Jun 26 '24 Sale 38.47 2,000 76,940 49,487 Jun 27 06:48 PM Kelsey Stephen Michael See Remarks Jun 25 '24 Option Exercise 4.09 16,467 67,350 285,540 Jun 26 04:26 PM Kelsey Stephen Michael See Remarks Jun 24 '24 Option Exercise 4.09 200 818 269,273 Jun 26 04:26 PM Kelsey Stephen Michael See Remarks Jun 25 '24 Sale 39.06 16,467 643,152 269,073 Jun 26 04:26 PM Kelsey Stephen Michael See Remarks Jun 24 '24 Sale 39.00 200 7,800 269,073 Jun 26 04:26 PM GOLDSMITH MARK A See Remarks Jun 17 '24 Sale 37.39 11,950 446,770 311,885 Jun 20 04:14 PM Anders Jack Chief Financial Officer Jun 17 '24 Sale 37.39 1,893 70,775 101,176 Jun 20 04:13 PM Horn Margaret A Chief Operating Officer Jun 17 '24 Sale 37.39 4,415 165,064 136,651 Jun 20 04:12 PM Kelsey Stephen Michael See Remarks Jun 17 '24 Sale 37.39 3,349 125,209 269,073 Jun 20 04:11 PM Cislini Jeff General Counsel Jun 17 '24 Sale 37.39 1,757 65,690 51,487 Jun 20 04:11 PM Wei Lin Chief Medical Officer Jun 17 '24 Sale 37.39 5,589 208,954 70,851 Jun 20 04:10 PM GOLDSMITH MARK A See Remarks Jun 03 '24 Option Exercise 4.09 7,500 30,675 329,822 Jun 05 04:18 PM GOLDSMITH MARK A See Remarks Jun 03 '24 Sale 39.99 7,500 299,942 322,322 Jun 05 04:18 PM Cislini Jeff General Counsel May 21 '24 Sale 39.11 1,500 58,671 52,874 May 22 04:11 PM Anders Jack Chief Financial Officer May 03 '24 Option Exercise 2.68 10,000 26,800 111,959 May 03 07:36 PM Anders Jack Chief Financial Officer May 03 '24 Sale 40.03 10,000 400,260 101,959 May 03 07:36 PM GOLDSMITH MARK A See Remarks Apr 10 '24 Sale 35.33 10,000 353,346 30,424 Apr 12 08:08 PM GOLDSMITH MARK A See Remarks Apr 10 '24 Sale 35.48 7,500 266,122 452,879 Apr 12 08:08 PM Patel Sushil Director Apr 10 '24 Option Exercise 16.80 2,155 36,204 17,855 Apr 12 04:23 PM Patel Sushil Director Apr 10 '24 Sale 37.00 2,155 79,735 15,700 Apr 12 04:23 PM Cislini Jeff General Counsel Mar 27 '24 Sale 30.99 1,500 46,481 54,374 Mar 28 04:11 PM Cislini Jeff General Counsel Mar 18 '24 Sale 31.58 1,252 39,542 55,874 Mar 20 04:45 PM Kelsey Stephen Michael See Remarks Mar 18 '24 Sale 31.58 2,123 67,051 270,909 Mar 20 04:45 PM Horn Margaret A Chief Operating Officer Mar 18 '24 Sale 31.58 2,914 92,033 139,553 Mar 20 04:44 PM GOLDSMITH MARK A See Remarks Mar 18 '24 Sale 31.58 5,788 182,804 460,379 Mar 20 04:44 PM Anders Jack Chief Financial Officer Mar 18 '24 Sale 31.58 1,261 39,826 101,959 Mar 20 04:43 PM Horn Margaret A Chief Operating Officer Mar 11 '24 Option Exercise 4.09 15,735 64,356 158,202 Mar 13 04:32 PM Horn Margaret A Chief Operating Officer Mar 12 '24 Option Exercise 4.09 7,936 32,458 150,403 Mar 13 04:32 PM Horn Margaret A Chief Operating Officer Mar 11 '24 Sale 34.02 15,735 535,306 142,467 Mar 13 04:32 PM Horn Margaret A Chief Operating Officer Mar 12 '24 Sale 34.07 7,936 270,345 142,467 Mar 13 04:32 PM Cislini Jeff General Counsel Jan 22 '24 Sale 27.00 1,500 40,500 36,126 Jan 24 04:12 PM Kelsey Stephen Michael See Remarks Jan 08 '24 Sale 29.01 3,337 96,809 221,632 Jan 10 04:26 PM Kelsey Stephen Michael See Remarks Jan 02 '24 Sale 29.10 13,330 387,884 224,969 Jan 04 04:06 PM Kelsey Stephen Michael See Remarks Dec 27 '23 Sale 29.01 33,334 966,996 238,299 Dec 29 04:14 PM Anders Jack Chief Financial Officer Dec 18 '23 Sale 25.90 1,775 45,976 76,416 Dec 20 05:10 PM GOLDSMITH MARK A See Remarks Dec 18 '23 Sale 25.90 8,165 211,488 376,167 Dec 20 05:08 PM Cislini Jeff General Counsel Dec 18 '23 Sale 25.90 1,229 31,833 37,284 Dec 20 05:08 PM Kelsey Stephen Michael See Remarks Dec 18 '23 Sale 25.90 2,088 54,083 271,633 Dec 20 05:07 PM Horn Margaret A Chief Operating Officer Dec 15 '23 Option Exercise 4.09 5,000 20,450 109,460 Dec 19 07:30 PM Horn Margaret A Chief Operating Officer Dec 15 '23 Sale 26.64 5,000 133,183 104,460 Dec 19 07:30 PM Horn Margaret A Chief Operating Officer Dec 18 '23 Sale 25.90 2,993 77,524 101,467 Dec 19 07:30 PM Horn Margaret A Chief Operating Officer Dec 06 '23 Option Exercise 4.09 5,000 20,450 109,460 Dec 08 04:08 PM Horn Margaret A Chief Operating Officer Dec 06 '23 Sale 25.00 5,000 125,000 104,460 Dec 08 04:08 PM Cislini Jeff General Counsel Nov 20 '23 Sale 21.70 1,500 32,545 38,513 Nov 20 06:24 PM Horn Margaret A Chief Operating Officer Oct 25 '23 Option Exercise 0.54 7,500 4,050 104,460 Oct 25 06:20 PM GOLDSMITH MARK A See Remarks Oct 24 '23 Option Exercise 0.49 35,000 17,150 384,332 Oct 24 07:21 PM
Index RUT P/E - EPS (ttm) -1.13 Insider Own 46.14% Shs Outstand 102.20M Perf Week -3.91%
Market Cap 711.41M Forward P/E - EPS next Y -1.46 Insider Trans -5.59% Shs Float 57.71M Perf Month -13.65%
Income -116.49M PEG - EPS next Q -0.37 Inst Own 56.76% Short Float 18.74% Perf Quarter -33.00%
Sales 42.51M P/S 16.74 EPS this Y -22.90% Inst Trans -3.10% Short Ratio 11.79 Perf Half Y -14.54%
Book/sh 2.31 P/B 2.87 EPS next Y -9.82% ROA -30.62% Short Interest 10.81M Perf Year -11.94%
Cash/sh 3.01 P/C 2.21 EPS next 5Y - ROE -50.58% 52W Range 6.33 - 13.01 Perf YTD -32.93%
Dividend Est. - P/FCF - EPS past 5Y - ROI -41.14% 52W High -48.94% Beta 0.81
Dividend TTM - Quick Ratio 7.49 Sales past 5Y 132.62% Gross Margin 94.15% 52W Low 4.90% ATR (14) 0.51
Dividend Ex-Date - Current Ratio 7.49 EPS Y/Y TTM 6.64% Oper. Margin -311.57% RSI (14) 37.15 Volatility 7.07% 5.66%
Employees 140 Debt/Eq 0.15 Sales Y/Y TTM 26.16% Profit Margin -274.04% Recom 1.11 Target Price 16.12
Option/Short Yes / Yes LT Debt/Eq 0.14 EPS Q/Q -0.64% Payout - Rel Volume 0.93 Prev Close 7.15
Sales Surprise 160.42% EPS Surprise 30.43% Sales Q/Q 36.15% Earnings Aug 07 BMO Avg Volume 917.01K Price 6.64
SMA20 -6.06% SMA50 -24.99% SMA200 -27.22% Trades
Volume 862,728 Change -7.13%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-17-24 Initiated Jefferies
Buy
$19
Apr-04-24 Initiated Cantor Fitzgerald
Overweight
Feb-12-24 Initiated Piper Sandler
Overweight
$18
Dec-08-23 Initiated B. Riley Securities
Buy
$16
Oct-20-22 Upgrade H.C. Wainwright
Neutral → Buy
$10
Sep-20-21 Initiated SVB Leerink
Outperform
$25
Aug-28-24 07:00AM
Aug-18-24 09:03AM
Aug-07-24 07:00AM
Jun-14-24 05:10AM
Jun-05-24 07:00AM
09:18AM
Loading…
May-23-24 09:18AM
07:00AM
May-08-24 01:53PM
08:10AM
07:00AM
May-07-24 10:00AM
Apr-01-24 04:48PM
Mar-20-24 05:31AM
Mar-18-24 02:52PM
08:10AM
07:00AM
Loading…
07:00AM
Mar-17-24 05:20PM
Mar-06-24 07:00AM
Mar-05-24 04:47PM
Feb-07-24 08:55AM
Jan-31-24 07:00AM
Jan-05-24 04:05PM
Jan-04-24 02:47AM
Jan-03-24 07:00AM
Nov-13-23 07:00AM
Nov-08-23 03:12PM
07:00AM
Nov-07-23 07:00AM
Oct-10-23 11:28AM
Oct-09-23 08:50AM
07:00AM
Loading…
Sep-18-23 07:00AM
Sep-06-23 07:00AM
Sep-05-23 07:00AM
Aug-29-23 05:08PM
Aug-28-23 07:00AM
Aug-10-23 07:00AM
Aug-07-23 07:00AM
Jul-24-23 07:00AM
Jul-10-23 07:00AM
Jun-01-23 07:00AM
May-09-23 07:00AM
Apr-18-23 04:30PM
Apr-03-23 07:00AM
Mar-27-23 07:00AM
Mar-14-23 08:11PM
Mar-10-23 10:15PM
(GlobeNewswire) -13.33%
+6.45%
Mar-06-23 07:00AM
Mar-01-23 07:00AM
Feb-28-23 07:00AM
Feb-02-23 07:00AM
Jan-25-23 07:00AM
Dec-15-22 07:00AM
Nov-10-22 07:00AM
Nov-07-22 07:00AM
Oct-19-22 07:00AM
Oct-05-22 08:10AM
Sep-06-22 07:00AM
Aug-13-22 08:27AM
Aug-10-22 07:00AM
Aug-02-22 07:00AM
Jun-27-22 07:00AM
Jun-20-22 07:26AM
Jun-08-22 07:00AM
May-11-22 07:00AM
May-09-22 07:00AM
Apr-19-22 07:22AM
Mar-28-22 07:00AM
Mar-08-22 04:57PM
Mar-03-22 09:41AM
Feb-28-22 07:00AM
Feb-02-22 07:00AM
Jan-24-22 07:00AM
Jan-11-22 09:37AM
Dec-21-21 06:38PM
Nov-11-21 07:00AM
Nov-10-21 10:42AM
Nov-09-21 07:00AM
Nov-01-21 07:00AM
Sep-30-21 04:31PM
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Boxer Capital Management, LLC Member of group owning over 10 Oct 22 '24 Proposed Sale 7.15 127,600 912,340 Oct 22 08:50 PM Boxer Capital Management, LLC Member of group owning over 10 Oct 21 '24 Proposed Sale 7.46 500,000 3,730,000 Oct 22 12:03 PM Third Rock Ventures IV, L.P. 10% Owner Sep 13 '24 Sale 10.53 67,400 709,756 16,859,075 Sep 17 04:48 PM Third Rock Ventures IV, L.P. Affiliate Sep 13 '24 Proposed Sale 10.50 67,400 707,700 Sep 13 05:43 PM Third Rock Ventures IV, L.P. 10% Owner Sep 05 '24 Sale 11.56 75,000 867,135 16,926,475 Sep 09 07:19 PM Third Rock Ventures IV, L.P. Affiliate Sep 05 '24 Proposed Sale 11.68 75,000 876,000 Sep 05 05:01 PM Third Rock Ventures IV, L.P. 10% Owner Aug 30 '24 Sale 11.60 175,000 2,029,702 17,001,475 Sep 04 08:42 PM Third Rock Ventures IV, L.P. Affiliate Aug 30 '24 Proposed Sale 11.83 175,000 2,070,250 Aug 30 05:24 PM Third Rock Ventures IV, L.P. 10% Owner Aug 27 '24 Sale 11.55 25,000 288,665 17,176,475 Aug 29 04:40 PM Third Rock Ventures IV, L.P. Affiliate Aug 27 '24 Proposed Sale 11.40 25,000 285,000 Aug 27 04:53 PM Third Rock Ventures IV, L.P. 10% Owner Aug 19 '24 Sale 10.09 150,000 1,513,920 17,201,475 Aug 20 05:59 PM Third Rock Ventures IV, L.P. 10% Owner Aug 16 '24 Sale 9.79 135,000 1,321,448 17,351,475 Aug 20 05:59 PM Third Rock Ventures IV, L.P. Affiliate Aug 19 '24 Proposed Sale 10.68 150,000 1,602,000 Aug 19 05:35 PM Third Rock Ventures IV, L.P. Affiliate Aug 16 '24 Proposed Sale 9.96 135,000 1,344,600 Aug 16 05:14 PM Third Rock Ventures IV, L.P. 10% Owner Jul 31 '24 Sale 9.93 100,000 993,380 17,526,475 Aug 01 05:51 PM Third Rock Ventures IV, L.P. 10% Owner Jul 30 '24 Sale 9.80 95,000 931,114 17,626,475 Aug 01 05:51 PM Third Rock Ventures IV, L.P. 10% Owner Aug 01 '24 Sale 9.80 40,000 392,000 17,486,475 Aug 01 05:51 PM Third Rock Ventures IV, L.P. Affiliate Aug 01 '24 Proposed Sale 9.45 40,000 378,000 Aug 01 05:30 PM Third Rock Ventures IV, L.P. Affiliate Jul 31 '24 Proposed Sale 9.85 100,000 985,000 Jul 31 05:32 PM Third Rock Ventures IV, L.P. Affiliate Jul 30 '24 Proposed Sale 9.70 95,000 921,500 Jul 30 05:15 PM Third Rock Ventures IV, L.P. 10% Owner Jul 26 '24 Sale 9.84 50,000 491,950 17,721,475 Jul 30 04:15 PM Third Rock Ventures IV, L.P. Affiliate Jul 26 '24 Proposed Sale 9.75 50,000 487,500 Jul 26 05:41 PM Third Rock Ventures IV, L.P. 10% Owner Jul 24 '24 Sale 9.82 200,000 1,963,160 17,872,074 Jul 26 04:15 PM Third Rock Ventures IV, L.P. 10% Owner Jul 25 '24 Sale 9.87 100,599 992,771 17,771,475 Jul 26 04:15 PM Third Rock Ventures IV, L.P. 10% Owner Jul 22 '24 Sale 9.78 262,740 2,570,096 18,197,074 Jul 24 04:15 PM Third Rock Ventures IV, L.P. 10% Owner Jul 23 '24 Sale 9.79 125,000 1,223,350 18,072,074 Jul 24 04:15 PM Third Rock Ventures IV, L.P. 10% Owner Jul 18 '24 Sale 9.81 191,490 1,878,479 18,459,814 Jul 22 04:15 PM Third Rock Ventures IV, L.P. 10% Owner Jul 17 '24 Sale 9.79 550,171 5,386,339 18,651,304 Jul 18 04:15 PM MVA Investors, LLC Jul 01 '24 Sale 8.87 110,731 982,184 203,793 Jul 02 08:56 PM MVA Investors, LLC Jul 02 '24 Sale 8.68 95,000 824,600 108,793 Jul 02 08:56 PM MVA Investors, LLC Jun 28 '24 Sale 8.57 29,000 248,530 314,524 Jul 02 08:56 PM MVA Investors, LLC Jun 07 '24 Sale 6.88 77,000 529,760 343,524 Jun 07 09:14 PM MVA Investors, LLC Jun 06 '24 Sale 7.24 63,000 456,120 420,524 Jun 07 09:14 PM MVA Investors, LLC May 02 '24 Sale 7.56 75,000 567,000 543,524 May 03 09:34 PM MVA Investors, LLC May 01 '24 Sale 7.43 75,000 557,250 618,524 May 03 09:34 PM MVA Investors, LLC May 03 '24 Sale 7.61 60,000 456,600 483,524 May 03 09:34 PM Third Rock Ventures IV, L.P. 10% Owner Feb 20 '24 Sale 12.00 162,500 1,950,000 19,201,475 Feb 21 05:52 PM Weber Barbara Chief Executive Officer Feb 06 '24 Sale 12.56 4,681 58,806 1,539,624 Feb 08 09:14 PM Weber Barbara Chief Executive Officer Feb 07 '24 Sale 12.62 4,457 56,246 1,535,167 Feb 08 09:14 PM Barry Douglas General Counsel Feb 06 '24 Sale 12.56 1,422 17,864 45,335 Feb 08 09:09 PM Barry Douglas General Counsel Feb 07 '24 Sale 12.62 1,354 17,087 43,981 Feb 08 09:09 PM Beckman Daniella Chief Financial Officer Feb 06 '24 Sale 12.56 1,908 23,969 134,214 Feb 08 09:08 PM Beckman Daniella Chief Financial Officer Feb 07 '24 Sale 12.62 1,817 22,930 132,397 Feb 08 09:08 PM Crystal Adam See Remarks Feb 06 '24 Sale 12.56 4,288 53,868 123,561 Feb 08 09:04 PM Crystal Adam See Remarks Feb 07 '24 Sale 12.62 4,083 51,527 119,478 Feb 08 09:04 PM Crystal Adam See Remarks Nov 01 '23 Sale 8.39 7,507 62,994 81,250 Nov 02 04:49 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
